Financial statements Smerud Medical Research Poland
Balance sheet data of SMERUD MEDICAL RESEARCH POLAND
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 44 382,06 | 14 416,91 | 53 278,08 | 90 494,13 | 125 322,61 | 427 512,40 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 44 382,06 | 14 416,91 | 53 278,08 | 90 494,13 | 125 322,61 | 427 512,40 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 44 382,06 | 14 416,91 | 53 278,08 | 90 494,13 | 125 322,61 | 427 512,40 |
| A. Equity | -2 431 457,43 | -2 677 587,47 | -2 972 544,77 | -3 417 850,27 | -3 550 352,18 | -3 382 060,50 |
| B. Liabilities and provisions for liabilities | 2 475 839,49 | 2 692 004,38 | 3 025 822,85 | 3 508 344,40 | 3 675 674,79 | 3 809 572,90 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 2 475 839,49 | 2 692 004,38 | 2 999 130,08 | 3 496 619,65 | 3 675 674,79 | 3 809 572,90 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD